SI2917209T1 - 1-(1-(benzoil)-pirrolidin-2-karbonil)-pirrolidin-2-karbonitril-derivati - Google Patents
1-(1-(benzoil)-pirrolidin-2-karbonil)-pirrolidin-2-karbonitril-derivatiInfo
- Publication number
- SI2917209T1 SI2917209T1 SI201330601A SI201330601A SI2917209T1 SI 2917209 T1 SI2917209 T1 SI 2917209T1 SI 201330601 A SI201330601 A SI 201330601A SI 201330601 A SI201330601 A SI 201330601A SI 2917209 T1 SI2917209 T1 SI 2917209T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pyrrolidine
- benzoyl
- carbonyl
- carbonitrile derivatives
- carbonitrile
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12382446.8A EP2730571A1 (en) | 2012-11-12 | 2012-11-12 | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives |
| EP13794837.8A EP2917209B1 (en) | 2012-11-12 | 2013-11-11 | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives |
| PCT/EP2013/073460 WO2014072498A1 (en) | 2012-11-12 | 2013-11-11 | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2917209T1 true SI2917209T1 (sl) | 2017-05-31 |
Family
ID=47278735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201330601A SI2917209T1 (sl) | 2012-11-12 | 2013-11-11 | 1-(1-(benzoil)-pirrolidin-2-karbonil)-pirrolidin-2-karbonitril-derivati |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US10125097B2 (sl) |
| EP (2) | EP2730571A1 (sl) |
| JP (1) | JP6203278B2 (sl) |
| KR (1) | KR102151290B1 (sl) |
| CN (1) | CN104903314B (sl) |
| AU (1) | AU2013343430B2 (sl) |
| BR (1) | BR112015010377A8 (sl) |
| CA (1) | CA2890042C (sl) |
| CY (1) | CY1118818T1 (sl) |
| DK (1) | DK2917209T3 (sl) |
| EA (1) | EA028422B1 (sl) |
| ES (1) | ES2621672T3 (sl) |
| HK (1) | HK1214597A1 (sl) |
| HR (1) | HRP20170485T1 (sl) |
| HU (1) | HUE032472T2 (sl) |
| LT (1) | LT2917209T (sl) |
| ME (1) | ME02706B (sl) |
| MX (1) | MX367488B (sl) |
| NZ (1) | NZ709096A (sl) |
| PL (1) | PL2917209T3 (sl) |
| PT (1) | PT2917209T (sl) |
| RS (1) | RS55865B1 (sl) |
| SI (1) | SI2917209T1 (sl) |
| WO (1) | WO2014072498A1 (sl) |
| ZA (1) | ZA201504269B (sl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2730571A1 (en) | 2012-11-12 | 2014-05-14 | Universitat De Barcelona | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives |
| EP3031458A1 (en) * | 2014-12-09 | 2016-06-15 | Iproteos S.L. | Use of 1-[(2-phenylcycloprop-1-yl)carbonyl]-2-[(1,3-thiazolidin-3-yl)carbonyl]perhydroindole in the treatment of schizophrenia-associated cognitive deficits |
| AU2018386298B2 (en) | 2017-12-15 | 2023-09-07 | Praxis Biotech LLC | Inhibitors of fibroblast activation protein |
| US11504364B2 (en) | 2018-12-21 | 2022-11-22 | Praxis Biotech LLC | Inhibitors of fibroblast activation protein |
| US20230250058A1 (en) | 2020-07-07 | 2023-08-10 | Accure Therapeutics, S.L. | 1-[1-(4-benzyloxy-3,5-difluoro-benzoyl)-4-fluoro-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile |
| JP2024506996A (ja) * | 2020-12-28 | 2024-02-15 | サラワク バイオダイバーシティ カウンシル | 神経変性疾患を治療するための化合物及びその単離方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2511605B2 (ja) * | 1990-06-04 | 1996-07-03 | ファイザー・インコーポレーテッド | 芳香性ピロリジンおよびチアゾリヂンアミド類 |
| US6159938A (en) | 1994-11-21 | 2000-12-12 | Cortech, Inc. | Serine protease inhibitors comprising α-keto heterocycles |
| HUT76640A (en) * | 1995-08-17 | 1997-10-28 | Chinoin Gyogyszer Es Vegyeszet | Compounds of pharmaceutical activity cyclic amide derivatives, pharmaceutical compositions containing them, process for producing them and their use |
| DE19603510A1 (de) | 1996-02-01 | 1997-08-07 | Knoell Hans Forschung Ev | Die Verwendung von Terrecyclolsäure A und Terrecyclolsäure A-Derivate als neue Inhibitoren der humanen Prolyl-Oligopeptidase |
| MXPA03000223A (es) * | 2000-07-19 | 2003-06-06 | Hoffmann La Roche | Derivados de pirrolidina como inhibidores de la enzima conversor de endotelina. |
| FI20011466A0 (fi) * | 2001-07-04 | 2001-07-04 | Orion Corp | Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä, niiden valmistusmenetelmiä ja käyttö |
| FI20030014A0 (fi) | 2003-01-03 | 2003-01-03 | Orion Corp | Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä |
| FI20031018A0 (fi) | 2003-07-04 | 2003-07-04 | Orion Corp | Parannus aivovammasta toipumiseen |
| JP4630192B2 (ja) | 2003-09-24 | 2011-02-09 | 日本化薬株式会社 | プロリルオリゴペプチダーゼ阻害剤 |
| US7667044B2 (en) | 2003-11-03 | 2010-02-23 | Probiodrug Ag | Compounds for the treatment of neurological disorders |
| EP1760076A1 (en) * | 2005-09-02 | 2007-03-07 | Ferring B.V. | FAP Inhibitors |
| ES2302473B1 (es) | 2006-12-22 | 2009-06-12 | Universidad De Barcelona | Agente terapeutico para el tratamiento del desorden afectivo bipolar en mamiferos. |
| EP2389176A4 (en) * | 2009-01-23 | 2012-08-01 | Univ Sydney | NEW THERAPY FOR METABOLIC DISEASE |
| EP2730571A1 (en) | 2012-11-12 | 2014-05-14 | Universitat De Barcelona | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives |
-
2012
- 2012-11-12 EP EP12382446.8A patent/EP2730571A1/en not_active Withdrawn
-
2013
- 2013-11-11 US US14/436,715 patent/US10125097B2/en active Active
- 2013-11-11 JP JP2015541169A patent/JP6203278B2/ja active Active
- 2013-11-11 DK DK13794837.8T patent/DK2917209T3/en active
- 2013-11-11 SI SI201330601A patent/SI2917209T1/sl unknown
- 2013-11-11 PT PT137948378T patent/PT2917209T/pt unknown
- 2013-11-11 RS RS20170362A patent/RS55865B1/sr unknown
- 2013-11-11 ME MEP-2017-76A patent/ME02706B/me unknown
- 2013-11-11 NZ NZ709096A patent/NZ709096A/en unknown
- 2013-11-11 PL PL13794837T patent/PL2917209T3/pl unknown
- 2013-11-11 EP EP13794837.8A patent/EP2917209B1/en active Active
- 2013-11-11 MX MX2015005931A patent/MX367488B/es active IP Right Grant
- 2013-11-11 ES ES13794837.8T patent/ES2621672T3/es active Active
- 2013-11-11 BR BR112015010377A patent/BR112015010377A8/pt not_active Application Discontinuation
- 2013-11-11 EA EA201590942A patent/EA028422B1/ru not_active IP Right Cessation
- 2013-11-11 CN CN201380059126.XA patent/CN104903314B/zh active Active
- 2013-11-11 KR KR1020157015736A patent/KR102151290B1/ko active IP Right Grant
- 2013-11-11 AU AU2013343430A patent/AU2013343430B2/en active Active
- 2013-11-11 WO PCT/EP2013/073460 patent/WO2014072498A1/en active Application Filing
- 2013-11-11 LT LTEP13794837.8T patent/LT2917209T/lt unknown
- 2013-11-11 CA CA2890042A patent/CA2890042C/en active Active
- 2013-11-11 HU HUE13794837A patent/HUE032472T2/en unknown
-
2015
- 2015-06-12 ZA ZA2015/04269A patent/ZA201504269B/en unknown
-
2016
- 2016-03-07 HK HK16102568.0A patent/HK1214597A1/zh unknown
-
2017
- 2017-03-22 HR HRP20170485TT patent/HRP20170485T1/hr unknown
- 2017-04-06 CY CY20171100410T patent/CY1118818T1/el unknown
-
2018
- 2018-09-26 US US16/142,907 patent/US10611727B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1209747A1 (en) | 1-(cycloalkyl-carbonyl)proline derivative 1-() | |
| HK1244004A1 (zh) | 内酰胺激酶抑制劑 | |
| ZA201407632B (en) | Triazolone compounds as mpges-1 inhibitors | |
| HK1206744A1 (en) | Isoindolone derivatives | |
| EP2884977A4 (en) | N-ALKYLATED INDAZOLE AND INDOLE COMPOUNDS AS RORGAMMAT INHIBITORS AND USES THEREOF | |
| HK1214518A1 (zh) | 經取代之苯甲醯基 -氟- -亞胺基- -甲基- -二氫嘧啶- -酮衍生物 | |
| AP2015008591A0 (en) | Heterocyclic compounds | |
| HK1202543A1 (en) | Azaheterocyclic compounds | |
| HK1214597A1 (zh) | 苯甲酰基 -吡咯烷- -羰基 -吡咯烷- -甲腈衍生物 | |
| HK1209115A1 (en) | Imidazole derivative | |
| HK1202860A1 (en) | Novel 1-substituted indazole derivative 1- | |
| HK1213253A1 (zh) | 新型吡唑衍生物 | |
| HRP20180647T1 (hr) | Derivat hidantoina | |
| GB201217285D0 (en) | Indole derivatives | |
| HK1221954A1 (zh) | β- -吡喃葡糖基 -吲哚化合物 | |
| EP2934144A4 (en) | INDAZOL COMPOUNDS AS AN ALDOSTERONE SYNTHESIS HEMMER | |
| GB201219296D0 (en) | Pyrazole derivatives | |
| GB201202400D0 (en) | Nitrogen-containing heterocyclic compounds |